Targeted next-generation sequencing for genetic diagnosis of 160 patients with primary immunodeficiency in south China

Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
Hassan AbolhassaniLennart Hammarström

Abstract

Primary immunodeficiency disorders (PID) is a group of heterogeneous diseases mainly characterized by severe and recurrent infections and an increased susceptibility to lymphoproliferative, atopic, and autoimmune conditions. The clinical diagnosis should preferably be complemented by a genetic diagnosis. To date, PID-related reports from China seldom attempt to make a genetic test for their patients. Our study aimed to evaluate demographic data, clinical manifestations, and molecular diagnosis of PID patients from southern China. Moreover, by comparison with previous reports, we provide a picture of the current status of PID in mainland China. A total number of 160 pediatric PID patients (106 males and 54 females) were enrolled, and targeted next-generation sequencing was conducted using 269 PID-related genes and subsequently confirmed by Sanger sequencing and familial segregation analysis. The autoinflammatory disease group was the most common subcategory of PID (20%), followed by immune dysregulation (17.5%) and combined immunodeficiencies (16.2%). Antibody deficiency disorders were identified in only 11.9% of the cohort. The putative causative gene was identified in 70 patients (43.8%), and an X-linked pattern was found in 4...Continue Reading

References

Jan 19, 2011·Journal of Clinical Immunology·Lin-Lin WangTong-Xin Chen
Jan 10, 2012·Annals of the New York Academy of Sciences·Sudhir GuptaShobha Sehgal
Jan 22, 2013·World Journal of Pediatrics : WJP·Xian QinXiao-Dong Zhao
Sep 5, 2013·European Journal of Dermatology : EJD·Ying-Yang XuHong-Yu Zhang
Apr 5, 2014·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Ying-Yang XuHong-Yu Zhang
Jun 20, 2014·Journal of Clinical Immunology·Huan XuLi-Ping Jiang
Sep 13, 2014·Journal of Immunology Research·Lin-Lin WangTong-Xin Chen
Jan 31, 2015·Chinese Medical Journal·Lian-Jun LinXin-Min Liu
Mar 20, 2016·Journal of Clinical Immunology·Mingyan FangLennart Hammarström
Sep 17, 2017·The Journal of Allergy and Clinical Immunology·Hassan AbolhassaniAsghar Aghamohammadi
Jun 21, 2018·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Hassan AbolhassaniLennart Hammarström

❮ Previous
Next ❯

Citations

Jul 29, 2020·Expert Review of Clinical Immunology·Hassan AbolhassaniAsghar Aghamohammadi
Aug 22, 2020·Expert Review of Clinical Immunology·Ivan K Chinn, Jordan S Orange

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Disease Therapy

In autoimmune diseases, the immune system responds and attacks self-antigens and damages or impairs the function of the tissues. The treatment for autoimmune diseases often involves immunosuppressive agents, but newer treatments are being investigated. Discover the latest research on autoimmune disease therapy here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.